Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 20 | Rare Historical Photos

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

International Business Times

Pfizer's 2024 Revenue Forecast Fails to Meet Wall Street Expectations

Amid a dismal financial outlook for 2024 and falling sales of COVID-19 products, Pfizer shares see a 7% tumble triggering Wall Street worries.

Top News

Pfizer Expects To Complete Purchase Of Seagen On Thursday

Pfizer announced Tuesday that it expects to complete this week its $43 billion acquisition of cancer-focused biotech company Seagen after clearing key regulatory hurdles.

International Business Times

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks Move Higher as CPI Falls to 5-month Low

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.48%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. The S&P 500 climbed to a 20-month high, while...

Barchart

Stocks Slightly Higher on Benign U.S. CPI Report

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.22%. Stocks this morning are posting modest gains, with the...

Barchart

Markets Today: Stocks Gain on Friendly U.S Nov CPI Report

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.17%, and Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.31%. Stock index futures this morning are moderately higher after the U.S. Nov CPI report matched expectations and eased slightly, bolstering speculation the Fed will start cutting interest...

Barchart

New COVID-19 vaccines hit pharmacy shelves

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

AAP

Read news from The Economist, FT, and more,
with one subscription

Competition cop Lina Khan’s antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Fortune

How to Buy PFE For a 7% Discount, or Achieve a 16% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart

‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise

Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn’t spoken out

The Guardian - UK

Stocks Mixed Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. Stocks this morning are mixed, with the Dow Jones...

Barchart

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK

Texas lawsuit claims Pfizer exaggerated effectiveness of Covid vaccine

State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death

The Guardian - US

Texas attorney general sues Pfizer, claiming vaccines didn’t end pandemic quickly enough

Experts argue other assertions made in the lawsuit filing are completely unsubstantiated, such as one claiming that vaccinated people were more likely to die from COVID-19, which Texas health data disputes.

The Texas Tribune

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

Medical Daily

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

The Independent UK

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Conversation

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

Get all your
news in one place.

100's of premium titles.
One news app.

USA Today Sports Media Group

Travis Kelce took a playful swipe at Aaron Rodgers in his interview with The Wall Street Journal

Rodgers isn't coming back from that one.

The Hindu

Exploring side effects

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…

Barchart

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

StockNews.com

Can Pfizer (PFE) and AbbVie (ABBV) Cure Your Portfolio's Ailments?

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.

The Independent UK

Syphilis cases in US newborns skyrocketed in 2022. Health officials suggest more testing

Syphilis cases in U.S. newborns again are on the rise

The Independent UK

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

Fortune

On 2023’s 100 Fastest-Growing Companies list, Tesla makes its debut and energy companies take off

Tesla was one of several industrial companies in the top five, while Pfizer and energy giants Chevron and ExxonMobil also put up big numbers.

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.